List of Figures
Figure 1-1: Pharmaceutical Market Size - Global vs. GCC (US$ Billion), 2018
Figure 1-2: GCC vs. Rest of World - Pharmaceutical Market Size (%), 2018
Figure 1-3: GCC - Population Statistics (Million), 2019
Figure 1-4: GCC - Population by Countries (%), 2019
Figure 1-5: GCC - Healthcare Expenditure by Countries (US$ Billion), 2018
Figure 1-6: GCC - Healthcare Expenditure by Countries (%), 2018
Figure 1-7: GCC - Pharmaceutical Market Size (US$ Billion), 2016 & 2018
Figure 1-8: GCC Pharmaceutical Market Size (US$ Billion), 2018 - 2025
Figure 1-9: MEA vs. GCC - Pharmaceutical Market Size (US$ Billion), 2018
Figure 1-10: GCC vs. Rest of MEA - Pharmaceutical Market Size (%), 2018
Figure 1-11: GCC - Pharmaceutical Market Size by Countries (US$ Billion), 2018
Figure 1-12: Pharmaceutical Market Size of Various GCC Countries (%), 2018
Figure 2-1: GCC - Number of Newly Diagnosed Cancer Cases & Deaths, 2018
Figure 2-2: GCC - Number of New Cancer Cases by Countries, 2018
Figure 2-3: GCC - New Cancer Cases by Countries (%), 2018
Figure 2-4: GCC - Number of Cancer Related Deaths by Countries, 2018
Figure 2-5: GCC - New Cancer Cases by Countries (%), 2018
Figure 2-6: GCC - Number of Newly Diagnosed Cancer Cases, 2018 & 2030
Figure 2-7: GCC - Age Standardized Cancer Incidence Rate by Countries (per 100,000 People), 2018
Figure 2-8: GCC - Age Standardized Cancer Mortality Rate by Countries (per 100,000 People), 2018
Figure 2-9: GCC Pharmaceutical Market Size - Total vs. Cancer Drugs (US$ Billion), 2018
Figure 2-10: GCC - Cancer Drug Market Size by Countries (%), 2018
Figure 2-11: GCC - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-12: GCC - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-13: GCC - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-14: GCC - Cancer Cases by Gender (%), 2018
Figure 2-15: GCC - Cancer Deaths by Gender (%), 2018
Figure 2-16: GCC - Age Standardized Cancer Incidence & Mortality Rate (per 100,000 People), 2018
Figure 2-17: Saudi Arabia - Number of Cancer Cases & Deaths, 2018
Figure 2-18: Saudi Arabia - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-19: Saudi Arabia - New Diagnosed Cancer Cases by Gender (%), 2018
Figure 2-20: Saudi Arabia - Cancer Related Deaths by Gender (%), 2018
Figure 2-21: Saudi Arabia - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-22: UAE - Number of Cancer Cases & Deaths, 2018
Figure 2-23: UAE - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-24: UAE - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-25: UAE - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-26: Kuwait - Number of Cancer Cases & Deaths, 2018
Figure 2-27: Kuwait - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-28: Kuwait - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-29: Kuwait - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-30: Bahrain - Number of Cancer Cases & Deaths, 2018
Figure 2-31: Bahrain - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-32: Bahrain - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-33: Bahrain - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-34: Qatar - Number of Cancer Cases & Deaths, 2018
Figure 2-35: Qatar - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-36: Qatar - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-37: Qatar - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-38: Oman - Number of Cancer Cases & Deaths, 2018
Figure 2-39: Oman - Number of Cancer Cases & Deaths by Gender, 2018
Figure 2-40: Oman - New Diagnosed Cases by Cancer Type (%), 2018
Figure 2-41: Oman - Number of New Diagnosed Cases by Cancer Type, 2018
Figure 2-42: GCC - Total Adult Population & Diabetic Population (Million), 2017
Figure 2-43: GCC - Total Adult Population & Diabetic Population (%), 2017
Figure 2-44: GCC - Diabetic Population by Countries (Million), 2017
Figure 2-45: GCC - Diabetic Population by Countries (%), 2017
Figure 2-46: GCC - Diabetes Related Deaths by Countries, 2017
Figure 2-47: GCC - Diabetes Related Deaths by Countries (%), 2017
Figure 2-48: GCC - Diabetes Prevalence Rate by Countries (%), 2017
Figure 2-49: GCC - Age Standardized Diabetes Death Rate by Countries (Per 100,000 People), 2017
Figure 2-50: GCC - Diabetic Population (Billion), 2017, 2018 & 2045
Figure 2-51: Saudi Arabia - Total HIV Cases & Newly Diagnosed HIV Cases, 2017
Figure 2-52: Saudi Arabia - New Diagnosed HIV Cases, 2013 - 2017
Figure 2-53: Saudi Arabia - New Diagnosed HIV Cases by Gender, 2017
Figure 2-54: Saudi Arabia - New Diagnosed HIV Cases by Gender (%), 2017
Figure 2-55: Saudi Arabia - Total HIV Cases by Gender, 2017
Figure 2-56: Saudi Arabia - Total HIV Cases by Gender, 2017
Figure 2-57: Saudi Arabia - Cumulative HIV Related Deaths by Gender, 2017
Figure 2-58: Saudi Arabia - Cumulative Number of HIV Patients on Anti-retroviral Therapy, 2017
Figure 2-59: UAE - Cumulative Number of HIV Patients, 2012, 2014 & 2016
Figure 2-60: UAE - Number of New HIV Cases & Deaths, 2016
Figure 2-61: UAE - Cumulative Number of HIV Patients on Anti-retroviral Therapy, 2012, 2014 & 2018
Figure 2-62: UAE - Cumulative Number of HIV Patients, 2014 - 2018
Figure 2-63: Bahrain - HIV Associated New Cases & Deaths, 2016
Figure 2-64: Bahrain - Patients Receiving Antiretroviral Therapy (%), 2012, 2014 & 2016
Figure 2-65: Qatar - Cumulative Number of HIV Cases & Patients on Antiretroviral Therapy, 1984 - 2014
Figure 2-66: Qatar - HIV Patients on Anti-Retroviral Therapy, 1984 - 2014
Figure 2-67: Oman - Cumulative HIV Cases, 2014, 2016 & 2018
Figure 2-68: Oman - Cumulative HIV Cases by Gender, 2018
Figure 2-69: Oman - Cumulative HIV Cases by Gender (%), 2018
Figure 2-70: Oman - Cumulative HIV Cases by Age, 2018
Figure 2-71: GCC - Age Standardized Coronary Heart Disease Death Rate by Countries, 2017
Figure 2-72: GCC - CHD Related Deaths by Countries, 2017
Figure 2-73: GCC - CHD Related Deaths by Countries (%), 2017
Figure 2-74: GCC - Age Standardized Hypertension Death Rate by Countries, 2017
Figure 2-75: GCC - Hypertension Related Deaths by Countries, 2017
Figure 2-76: GCC - Hypertension Related Deaths by Countries (%), 2017
Figure 2-77: GCC - Age Standardized Stroke Death Rate by Countries, 2017
Figure 2-78: GCC - Stroke Related Deaths by Countries, 2017
Figure 2-79: GCC - Stroke Related Deaths by Countries (%), 2017
Figure 2-80: GCC - Obese Population by Countries (%), 2019
Figure 2-81: GCC - Body Mass Index by Countries, 2019
Figure 2-82: Saudi Arabia - Obesity Prevalence Rate (%), 2017 & 2022
Figure 2-83: Saudi Arabia - Obesity Prevalence Rate by Gender (%), 2017 & 2022
Figure 2-84: UAE - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-85: UAE - Obese Adult Population (%), 2019
Figure 2-86: Kuwait - Prevalence Rate of Obesity & Overweight (%), 2016
Figure 2-87: Kuwait - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-88: Bahrain - Prevalence Rate of Obesity & Overweight (%), 2016
Figure 2-89: Bahrain - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-90: Qatar - Prevalence Rate of Obesity & Overweight (%), 2016
Figure 2-91: Qatar - Prevalence Rate of Obesity & Overweight by Gender (%), 2016
Figure 2-92: Oman - Obesity Prevalence Rate by Gender (%), 2016
Figure 2-93: GCC - Asthma Related Deaths by Countries, 2017
Figure 2-94: GCC - Asthma Related Deaths by Countries (%), 2017
Figure 2-95: GCC - Age Standardized Asthma Death Rate by Countries (per 100,000 People), 2017
Figure 2-96: GCC - Tuberculosis Related Deaths by Countries, 2017
Figure 2-97: GCC - Age Standardized Incidence Rate of Tuberculosis by Countries (Per 100,000 People), 2017
Figure 2-98: GCC - Asthma Related Deaths by Countries (%), 2017
Figure 2-99: GCC - Age Standardized Tuberculosis Death Rate by Countries (per 100,000 People), 2017
Figure 2-100: GCC - Influenza & Pneumonia Related Deaths by Countries, 2017
Figure 2-101: GCC - Influenza & Pneumonia Related Deaths by Countries (%), 2017
Figure 2-102: GCC - Age Standardized Influenza & Pneumonia Death Rate by Countries (per 100,000 People), 2017
Figure 2-103: GCC - COPD Prevalence Rate by Countries (%), 2018
Figure 2-104: GCC - COPD & Cystic Fibrosis Related Deaths by Countries, 2017
Figure 2-105: GCC - COPD & Cystic Fibrosis Related Deaths by Countries (%), 2017
Figure 2-106: GCC - Age Standardized COPD & Cystic Fibrosis Death Rate by Countries (per 100,000 People), 2017
Figure 2-107: GCC - Alzheimer/Dementia Related Deaths by Countries, 2017
Figure 2-108: GCC - Alzheimer/Dementia Related Deaths by Countries (%), 2017
Figure 2-109: GCC - Age Standardized Alzheimer/Dementia Death Rate by Countries (per 100,000 People), 2017
Figure 3-1: GCC - Types of Drug Registration Process
Figure 3-2: Process Map for GCC Centralized Registration
Figure 3-3: GCC - Innovative/Biological and Generic Drug Registration Fees for Evaluation Procedures (SAR/US$), 2019
Figure 3-4: GCC - Innovative/Biological and Generic Drug Registration Renewal Fees (SAR/US$), 2019
Figure 3-5: GCC - Registration Fees for Addition of New Pharmaceutical Form, New Strength & New Pack Size for Innovative/Biological Products (SAR/US$), 2019
Figure 3-6: GCC - Registration Fees for Addition of New Pharmaceutical Form, New Strength & New Pack Size for Generic Products (SAR/US$), 2019
Figure 3-7: GCC - Registration Fees for Addition of New Pharmaceutical Form, New Strength & New Pack Size for Intravenous Generic Products (SAR/US$), 2019
Figure 3-8: Saudi Arabia - Regulatory Process for Pharmaceuticals
Figure 3-9: Kuwait - Regulatory Process for Pharmaceuticals
Figure 3-10: UAE - Regulatory Process for Pharmaceuticals
Figure 3-11: Bahrain - Regulatory Process for Pharmaceuticals
Figure 3-12: Qatar - Regulatory Process for Pharmaceuticals
Figure 3-13: Oman - Regulatory Process for Pharmaceuticals
Figure 5-1: GCC - Pharmaceutical Market Size - Generic vs. Others (US$ Billion), 2018
Figure 5-2: GCC - Pharmaceutical Market Size - Generic vs. Others (%), 2018
Figure 5-3: GCC - Generic Drug Market Size (US$ Billion), 2018 - 2025
Figure 5-4: GCC - Patented & OTC Pharmaceutical Market Size (US$ Billion), 2018
Figure 5-5: GCC - Share of Patented Products in Pharmaceutical Market by Countries (%), 2016
Figure 5-6: GCC - Share of OTC Products in Pharmaceutical Market by Countries (%), 2016
Figure 5-7: GCC - Biosimilars Market Size (US$ Million), 2019 & 2025
Figure 5-8: GCC - Strategies Considered by New Biosimilars Manufacturers
Figure 5-9: Key Stakeholders for Launch of Biosimilars
Figure 6-1: Pharmaceutical Market Size - Saudi Arabia vs. Rest of GCC (%), 2018
Figure 6-2: Pharmaceutical Market Size - Saudi Arabia vs. Rest of MEA (%), 2018
Figure 6-3: Saudi Arabia - Pharmaceutical Market Size (US$ Billion), 2018 - 2025
Figure 6-4: Saudi Arabia - Pharmaceutical Market Share by Channel of Distribution (%), 2018
Figure 6-5: Saudi Arabia - Pharmaceutical Market Size by indication (%), 2018
Figure 6-6: Saudi Arabia - Number of New Product Launched by Indication, 2018
Figure 6-7: Saudi Arabia - Sales Data of Leading Pharmaceutical Products (US$ Million), 2018
Figure 6-8: Saudi Arabia - Revenue of Leading Pharmaceutical Companies (US$ Million), 2018
Figure 6-9: Saudi Arabia - Generic & Branded Pharmaceutical Market Size (%), 2018
Figure 6-10: Saudi Arabia - OTC & Prescribed Pharmaceuticals Market Size (US$ Billion), 2018
Figure 6-11: Saudi Arabia - OTC & Prescribed Pharmaceutical Market Size (%), 2018
Figure 7-1: Pharmaceutical Market Size - UAE vs. Rest of GCC (%), 2018
Figure 7-2: Pharmaceutical Market Size - UAE vs. Rest of MEA (%), 2018
Figure 7-3: UAE - Pharmaceutical Market Size by Channel of Distribution (%), 2018
Figure 7-4: UAE - Pharmaceutical Market Size (US$ Billion), 2018 - 2025
Figure 7-5: UAE - Pharmaceutical Export Market by Region (%), 2017
Figure 7-6: UAE - Pharmaceutical Export Market by Countries (%), 2017
Figure 7-7: UAE - Pharmaceutical Export Market by Products (%), 2018
Figure 7-8: UAE - Pharmaceutical Market Size by Therapeutic Indication (US$ Million), 2018
Figure 7-9: UAE - Number of New Launched Pharmaceutical Product by Indication, 2018
Figure 7-10: UAE - Growth Rate of Leading Pharmaceutical Companies (%), 2018
Figure 7-11: UAE - Pharmaceutical Market Share by Type of Products (%), 2017
Figure 7-12: UAE - Pharmaceutical Market Share by Type of Products (%), 2018
Figure 7-13: UAE - Generic Drug Market Size (US$ Million), 2017 - 2025
Figure 8-1: Pharmaceutical Market Size - Kuwait vs. Rest of GCC (%), 2018
Figure 8-2: Pharmaceutical Market Size - Kuwait vs. Rest of MEA (%), 2018
Figure 8-3: Kuwait - Pharmaceutical Market Size (US$ Billion), 2018-2025
Figure 8-4: Kuwait - Pharmaceutical Market Size by Therapeutic Indication (%), 2018
Figure 8-5: Kuwait - Sales Data of Leading Pharmaceutical Products (US$ Million), 2018
Figure 8-6: Kuwait - Pharmaceutical Market Size - MNC vs. Regional Companies (%), 2016
Figure 8-7: Kuwait - Julphar Pharmaceutical Share in Regional Pharmaceutical sales (%), 2016
Figure 8-8: Kuwait - Pharmaceutical Market Size by Leading Companies (US$ Million), 2018
Figure 8-9: Kuwait - Generic Pharmaceutical Market Share (%), 2018 & 2025
Figure 8-10: Kuwait - Pharmaceutical Market by Type of Product (%), 2018
Figure 8-11: Kuwait - Generic Drug Market Share in Total market Size (%), 2018
Figure 8-12: Kuwait - OTC Pharmaceutical Market Share (%), 2018 & 2025
Figure 9-1: Bahrain - Pharmaceutical Market Size - Bahrain vs. Rest of GCC (%), 2018
Figure 9-2: Bahrain - Pharmaceutical Market Size (US$ Million), 2018 - 2025
Figure 9-3: Bahrain - Pharmaceutical Market Size - Import vs. Total Market (US$ Million), 2018
Figure 9-4: Bahrain - Pharmaceutical market Share - Import vs. Other Market (%), 2018
Figure 9-5: Bahrain - Pharmaceutical market Share by Therapeutic Agents (%), 2018
Figure 9-6: Bahrain - Market Size by Leading Pharmaceutical Companies (US$ Million), 2018
Figure 9-7: Bahrain - Share of Generics in Total Pharmaceutical Market (%) 2018 & 2025
Figure 9-8: Bahrain - Share of OTC in Total Pharmaceutical Market (%) 2018 & 2025
Figure 9-9: Bahrain - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2018
Figure 9-10: Bahrain - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2025
Figure 9-11: Bahrain - Generic Pharmaceutical Market Size (US$ Million), 2018 & 2025
Figure 9-12: Bahrain - OTC Pharmaceutical Market Size (US$ Million), 2018 & 2025
Figure 10-1: Qatar - Pharmaceutical Market Size (US$ Million), 2015 - 2018
Figure 10-2: Qatar - Pharmaceutical Market Size - Qatar vs. Rest of GCC (%), 2018
Figure 10-3: Qatar - Pharmaceutical Market Size - Qatar vs. Rest of MEA (%), 2018
Figure 10-4: Qatar - Pharmaceutical Market Size (US$ Million), 2018 - 2025
Figure 10-5: Qatar - Pharmaceutical Market Size by Product Type (US$ Million), 2018
Figure 10-6: Qatar - Pharmaceutical Market Size by Product Type (%), 2018
Figure 10-7: Qatar - Pharmaceutical Market Size by Type of Product (US$ Million), 2025
Figure 11-1: Oman - Pharmaceutical Market Size (US$ Million), 2012, 2016 & 2018
Figure 11-2: Pharmaceutical Market Size - Oman vs. Rest of GCC (%), 2018
Figure 11-3: Pharmaceutical Market Size - Oman vs. Rest of MEA (%), 2018
Figure 11-4: Oman - Pharmaceutical Market Size (US$ million), 2019 - 2025
Figure 11-5: Oman - Import, Export & Other Pharmaceutical Market Size (US$ Million), 2018
Figure 11-6: Oman - Import, Export & Other Pharmaceutical Market Size (%), 2018
Figure 11-7: Oman - Share of Generics in Total Pharmaceutical Market (%) 2016, 2018 & 2025
Figure 11-8: Oman - Share of OTC in Total Pharmaceutical Market (%) 2016, 2018 & 2025
Figure 11-9: Oman - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2018
Figure 11-10: Oman - Patented, Generics & OTC Pharmaceuticals Market Share (%), 2025
Figure 11-11: Oman - Generic Pharmaceutical Market Size (US$ Million), 2018 & 2025
Figure 11-12: Oman - OTC Pharmaceutical Market Size (US$ Million), 2018 & 2025
Figure 12-1: GCC - Pharmaceutical Import Market Size by Countries (US$ Billion), 2018
Figure 12-2: GCC - Pharmaceutical Import Market Size by Countries (%), 2018
Figure 12-3: GCC - Import Pharmaceutical Market Size (US$ Billion), 2016, 2017 & 2018
Figure 12-4: Saudi Arabia - Pharmaceutical Import Size (US$ Billion), 2016 - 2018
Figure 12-5: UAE - Pharmaceutical Import Size (US$ Billion), 2016 - 2018
Figure 12-6: Kuwait - Pharmaceutical Import Size (US$ Billion), 2016 - 2018
Figure 12-7: Bahrain - Pharmaceutical Import Size (US$ Million), 2016 - 2018
Figure 12-8: Qatar - Pharmaceutical Import Size (US$ Million), 2016 - 2018
Figure 12-9: Oman - Pharmaceutical Import Size (US$ Million), 2016 - 2018
Figure 12-10: GCC - Pharmaceutical Export Market Size by Countries (US$ Million), 2018
Figure 12-11: GCC - Pharmaceutical Export Market Size by Countries (%), 2018
Figure 12-12: GCC - Export Pharmaceutical Market Size (US$ Billion), 2016, 2017 & 2018
Figure 12-13: Saudi Arabia - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-14: UAE - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-15: Kuwait - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-16: Bahrain - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-17: Qatar - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 12-18: Oman - Pharmaceutical Export Size (US$ Million), 2016 - 2018
Figure 13-1: GCC - Number of Clinical Trials by Countries, 2019
Figure 13-2: GCC - Clinical Trials by Countries (%), 2019
Figure 13-3: GCC - Number of Clinical Trials by Status, 2019
Figure 13-4: GCC - Clinical Trials by Status (%), 2019
Figure 13-5: GCC - Number of Clinical Trial by Phase, 2019
Figure 13-6: GCC - Number of Clinical Trial by Phase (%), 2019
Figure 13-7: GCC - Numbers of Clinical Trials by Indications, 2019
Figure 13-8: GCC - Clinical Trials by Indications (%), 2019
Figure 13-9: GCC - Number of Cancer Related Clinical Trials by Countries, 2019
Figure 13-10: GCC - Cancer Related Clinical Trials by Countries (%), 2019
Figure 13-11: GCC - Number of Cancer Related Clinical Trials by Phase of Development, 2019
Figure 13-12: GCC - Number of Diabetes Related Clinical Trials by Countries, 2019
Figure 13-13: GCC - Diabetes Related Clinical Trials by Countries (%), 2019
Figure 13-14: GCC - Number of Diabetes Related Clinical Trials by Development Phase, 2019
Figure 13-15: GCC - Number of CVS Disorder Related Clinical Trials by Countries, 2019
Figure 13-16: GCC - CVS Disorder Related Clinical Trials by Countries (%), 2019
Figure 13-17: GCC - Number of CVS Disorders Related Clinical Trials by Development Phase, 2019
Figure 13-18: GCC - Number of Respiratory Disorder (Except Lung Cancer) Related Clinical trials by Countries, 2019
Figure 13-19: GCC - Respiratory Disorder (Except Lung Cancer) Related Clinical Trials by Countries (%), 2019
Figure 13-20: GCC - Number of Respiratory Disorders Related Clinical Trials by Development Phase, 2019
Figure 13-21: Saudi Arabia - Number of Clinical Trials by Development Phase, 2019
Figure 13-22: Saudi Arabia - Number of Clinical Trials by Status, 2019
Figure 13-23: Saudi Arabia - Numbers of Clinical Trials by Indications, 2019
Figure 13-24: Saudi Arabia - Clinical Trials by Indications (%), 2019
Figure 13-25: UAE - Clinical Trials in States of UAE (%), 2019
Figure 13-26: UAE - Number of Clinical Trials by Development Phase, 2019
Figure 13-27: UAE - Number of Clinical Trials by Status, 2019
Figure 13-28: UAE - Numbers of Clinical Trials by Indications, 2019
Figure 13-29: UAE - Clinical Trials by Indications (%), 2019
Figure 13-30: Kuwait - Number of Clinical Trials by Development Phase, 2019
Figure 13-31: Kuwait - Number of Clinical Trials by Status, 2019
Figure 13-32: Kuwait - Numbers of Clinical Trials by Indications, 2019
Figure 13-33: Kuwait - Clinical Trials by Indications (%), 2019
Figure 13-34: Bahrain - Number of Clinical Trials by Development Phase, 2019
Figure 13-35: Bahrain - Number of Clinical Trials by Status, 2019
Figure 13-36: Qatar - Number of Clinical Trials by Development Phase, 2019
Figure 13-37: Qatar - Number of Clinical Trials by Status, 2019
Figure 13-38: Qatar - Numbers of Clinical Trials by Indications, 2019
Figure 13-39: Kuwait - Clinical Trials by Indications (%), 2019
Figure 13-40: Oman - Number of Clinical Trials by Development Phase, 2019
Figure 13-41: Oman - Number of Clinical Trials by Status, 2019
Figure 14 1: Driving Factors for GCC Pharmaceutical Market
Figure 15-1: Challenges for GCC Pharmaceutical Market
Figure 16-1: GCC - Population Forecast by Countries (Million), 2025
Figure 16-2: GCC - Pharmaceutical Market Forecast by Countries (US$ Billion), 2025
Figure 16-3: GCC - Pharmaceutical Market Share Forecast by Countries (%), 2025
Figure 16-4: GCC - Cancer Drug Market Forecast (US$ Billion), 2018 & 2025
Figure 16-5: GCC - Generic Pharmaceutical Market Forecast (%), 2025